Cetera Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Cetera Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$259K	Buy	10,760 +125	+1%	+$2.93K	﹤0.01%	2045
2023 Q4	$245K	Buy	10,635 +210	+2%	+$4.22K	﹤0.01%	1536
2023 Q3	$212K	Buy	10,425 +23	+0.2%	+$516	﹤0.01%	1511
2023 Q2	$243K	Buy	10,402 +3	+0%	+$72	﹤0.01%	1410
2023 Q1	$242K	Sell	10,399 -636	-6%	-$15.9K	﹤0.01%	1397
2022 Q4	$278K	Sell	11,035 -710	-6%	-$19.1K	0.01%	1277
2022 Q3	$310K	Buy	11,745 +1,218	+12%	+$37.6K	0.01%	961
2022 Q2	$304K	Buy	+10,527	New	+$314K	0.01%	1039

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Cetera Advisors's IDNA Position: Q1 2024 in Review

Cetera Advisors increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 1.2% in Q1 2024, buying an estimated $2.93K and bringing the position to 10,760 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #2045.

Cetera Advisors first reported a position in IDNA in Q2 2022 and has held it in 8 quarters since. The position peaked at $310K in Q3 2022. 63 funds tracked by Wall St. Rank hold IDNA as of Q1 2024.

Cetera Advisors held 10,760 shares of iShares Genomics Immunology and Healthcare ETF worth $259K as of Q1 2024.
Cetera Advisors bought 125 iShares Genomics Immunology and Healthcare ETF shares in Q1 2024, an estimated $2.93K.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2045 holding.
Cetera Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2022 and has held it in 8 quarters since.
Cetera Advisors's iShares Genomics Immunology and Healthcare ETF position peaked at $310K in Q3 2022.
63 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.